U.S. Markets closed

Gilead charged $1,100 a day for this drug. Now it will launch a generic at quarter the price.

Ron Leuty
Gilead charged $1,100 a day for this drug. Now it will launch a generic at quarter the price.

The Foster City-based company said its generic versions of Harvoni, as well as Epclusa, will increase its market and reduce patient out-of-pocket expenses.